Total medical devices industry venture financing deals in July 2019 worth $540.5m were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 14.5% over the previous month and a drop of 5.5% when compared with the last 12-month average of $572.07m.

The US held an 83.2% share of the global medical devices industry venture financing deal value that totalled $649.89m in July 2019.

In terms of deal activity, the US recorded 50 deals during July 2019, marking a decrease of 24.2% over the previous month and a drop of 7.4% over the 12-month average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The US medical devices industry venture financing deals in July 2019: Top deals

The top five medical devices industry venture financing deals accounted for 58.7% of the overall value during July 2019.

The combined value of the top five medical devices venture financing deals stood at $317m, against the overall value of $540.5m recorded for the month.

The top five medical devices industry deals of July 2019 tracked by GlobalData were:

1) American Cancer Society, Andreessen Horowitz, Data Collective Venture Capital, Verily Life Sciences, GV Management Co, Kaiser Permanente Ventures, Perceptive Advisors, Polaris Partners, RA Capital Management, Roche Venture Fund, Section 32 and T. Rowe Price Associates’ $160m venture financing of Freenome

2) The $63m venture financing of Beta Bionics by ArrowMark Partners, Eventide Asset Management, Farallon Capital Management, Perceptive Advisors, RTW Investments and Soleus Capital Management

3) Perceptive Advisors, RTW Investments, Soleus Capital Management, SternAegis Ventures and Terumo’s $34m venture financing of Orchestra BioMed

4) The $30m venture financing of Procyrion by Bluebird Merchant Ventures, Fannin Partners, Scientific Health Development and State of Texas

5) Mithril Capital Management and Norwest Venture Partners’ venture financing of Neocis for $30m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.